Global Markets: United States FDA approves Johnson & Johnson vaccine

WINNIPEG, March 1 (MarketsFarm) – The following is a glance at the news moving markets in Canada and globally.

– The United States Food & Drug Administration approved the one-dose COVID-19 vaccine created by Johnson & Johnson on Saturday. The J&J vaccine was the fourth COVID-19 shot to receive approval in the U.S. after Pfizer/BioNTech, Moderna and AstraZeneca, which was approved just days before J&J. Nearly four million doses will be delivered to states starting on Tuesday. Health Canada received more data on the vaccine on Saturday, paving the way for it to be approved in the coming days. Canada has ordered more than 10 million doses of the J&J vaccine, with the option to acquire up to 28 million more.

– The British Columbia Supreme Court begins the first of three hearings on Monday regarding the arrest and detention of Huawei chief financial officer Meng Wanzhou. Meng’s lawyers will argue that then-U.S. president Donald Trump interfered with extradition proceedings, the Canadian Border Services Agency violated her Charter rights, and U.S. prosecutors went beyond their jurisdiction in investigating her.

– Former French president Nicolas Sarkozy has been sentenced to one year under house arrest for corruption and influence peddling by a Paris court on Monday. Sarkozy, who was France’s head of state from 2007 to 2012, was found guilty of trying to obtain information from a senior magistrate about a 2014 investigation into Sarkozy’s campaign finances. He is the first president in France’s modern history to be imprisoned.

About the author

Glacier FarmMedia Feed

GFM Network News

Glacier FarmMedia, a division of Glacier Media, is Canada's largest publisher of agricultural news in print and online.

Comments

explore

Stories from our other publications